Visgeneer (ROCO:4197) Total Payout Ratio: (As of Sep. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4197 Visgeneer Inc ROCO:4197
58 GF Score
Price NT$9.31
GF Value NT$12.40
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Visgeneer Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Visgeneer's current Total Payout Ratio is .

Visgeneer Total Payout Ratio Related Terms

Visgeneer Total Payout Ratio Historical Data

* Premium members only.

The historical data trend for Visgeneer's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Visgeneer Total Payout Ratio Chart

Visgeneer Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Visgeneer Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Total Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

ROCO:4197 vs VRTX, REGN, MRNA: Total Payout Ratio Comparison

For the Biotechnology subindustry, Visgeneer's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Visgeneer Total Payout Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Visgeneer's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Visgeneer's Total Payout Ratio falls into.


ROCO:4197
58GF Score
Visgeneer Inc ROCO:4197
Total Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Visgeneer Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Visgeneer's Total Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (-0 + 0 + -0) / 5.247
=0.00

Visgeneer's Total Payout Ratio for the quarter that ended in Jun. 2026 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (-0 + 0 + -0) / -6.709
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Visgeneer (ROCO:4197) Overvalued in 2026?

Based on GuruFocus' analysis, Visgeneer stock appears to be undervalued. The current stock price of NT$9.31 is trading 24.9% below its estimated GF Value™ of NT$12.40. GuruFocus considers Visgeneer to be Modestly Undervalued.

Key valuation signals for ROCO:4197:

  • Total Payout Ratio:
  • GF Value™: NT$12.40 vs. price of NT$9.31 (24.9% below fair value)
  • GF Score™: 58/100 with 3 warning signs

No single metric tells the full story. See the ROCO:4197 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Visgeneer Business Description

Address Number 335, Section 6, Zhonghua Road, Xiangshan District, Hsinchu, TWN, 30094
Visgeneer Inc is a Taiwan based Biotech company involved in developing and, manufacturing biomedical products in the areas of Bacterial Fermentation, Medical Device, Cosmetics/Skin Care, and Cancer Gene identification. Its products include Blood Glucose and Ketone Monitoring System, Ginkgo Biloba series, Peptide-Complex series, Hyaluronic Acid Essence Series and High-Quality Masks among others.
58GF Score

Get the complete analysis for ROCO:4197

Total Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$9.31
Price
NT$12.40
GF Value